1. Optimizing Quality of Life and Mental Health in Patients With Psoriasis

3. Program Introduction

4. Psoriasis and Psychological Comorbidities

5. Psoriasis: Psychosomatic Comorbidity Development

6. Development of Psoriasis: Psychosomatic Aspects

7. Results of SF-36 Quality of Life Inventory

8. Isolation, Anxiety, Depression: Ways to Solve the Psychosocial Problems in Psoriasis

9. Social Lives, Partnership, and Sexuality

10. Differences in the Appraisal of Touching Behavior Between Psoriasis Patients and Skin-Healthy Controls

11. Evaluation of Individual Risks for Comorbidities

12. Risk of Depression, Anxiety, and Suicidality

13. DSM, Diagnostic Criteria of Depression (by ICD-10 and DSM-5)

14. Clinical Features of the Most Common Anxiety Disorders in Psoriasis

15. Suicidal Thoughts and Common Skin Diseases

16. Common and Divergent Pathogenic Pathways of Depression, Anxiety, and Psoriasis

17. Balancing Patient Expectations vs Physician Objectives

18. Available Therapies for Psoriasis

19. Biologic Therapies for Psoriasis

20. PASI-75 and PASI-90 Responses

21. Psychodermatology Training

22. Six Basic Principles of Psychological-Based Interventions

23. Psoriasis and …

24. Explore and Explain How Brain and Psoriasis Interact

25. Summary

26. Abbreviations

27. Abbreviations (cont)